| 词条 | Joe M. McCord |
| 释义 |
| name = Joe Milton McCord |birth_date = {{b-da|March 3, 1945}} | residence = Denver, Colorado | citizenship = United States | ethnicity = United States | field = Biochemistry | work_institution = University of Colorado | alma_mater = Rhodes College, Duke University | doctoral_advisor = Irwin Fridovich | known_for = Discovery of superoxide dismutase }}Joe Milton McCord (born March 3, 1945) is an American biochemist. While serving as a graduate student, he and his supervisor Irwin Fridovich were the first to describe the enzymatic activity of superoxide dismutase.[1][2] McCord joined the board of directors of the LifeVantage Corporation (makers of the dietary supplement Protandim) in 2006, serving as the company's chief science officer from 2011 to 2012, and retired from the company in June 2013.[3] Academic BackgroundMcCord received a B.S. degree in chemistry from Rhodes College (graduated 1966) and a Ph.D. in biochemistry from Duke University (graduated 1970), where he also conducted postdoctoral research.{{citation needed|date=July 2013}} McCord is a past recipient of the Elliott Cresson Medal, the Discovery Award from the Society for Free Radical Biology and Medicine (SFRBM),[4]{{failed verification|date=December 2018}} and a Lifetime Achievement Award from the Oxygen Society.{{citation needed|date=December 2018}} LifeVantage/ProtandimMcCord served on the board of directors (Director of Science) of the LifeVantage Corporation beginning in 2006[5] and was listed by the SEC as an insider shareholder.[6] LifeVantage is a Utah-based multilevel marketing company that distributes an antioxidant dietary supplement known as Protandim. McCord co-authored 7 studies on the product[7][8][9][10][11][12][13] and participated in distributor training.[6] McCord served as Chief Scientific Officer for LifeVantage from June 2011 until September 2012, and then became a member of the company's science advisory board. LifeVantage announced McCord’s retirement in June 2013.[3][14] Under the terms of the separation agreement, McCord was to receive a payment of $1.7 million from the company.[14] References1. ^{{cite journal |vauthors=McCord JM, Fridovich I |title=Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein) |journal=J. Biol. Chem. |volume=244 |issue=22 |pages=6049–55 |date=November 1969 |pmid=5389100}} 2. ^{{cite journal |vauthors=Keele BB, McCord JM, Fridovich I |title=Superoxide dismutase from escherichia coli B. A new manganese-containing enzyme |journal=J. Biol. Chem. |volume=245 |issue=22 |pages=6176–81 |date=November 1970 |pmid=4921969}} 3. ^1 http://globenewswire.com/news-release/2013/06/25/556132/10037495/en/Dr-Joe-McCord-LifeVantage-Corporation-s-First-Chief-Science-Officer-Retires-From-Company.html{{full citation needed|date=July 2013}} 4. ^{{cite web | title=SFRBM - Society for Free Radical Biology and Medicine | url=http://www.sfrbm.org }} 5. ^http://www.allbusiness.com/company-activities-management/board-management/5376294-1.html{{full citation needed|date=July 2013}} 6. ^1 http://secwatch.com/mccord-joe-m{{full citation needed|date=July 2013}} 7. ^{{cite journal |vauthors=Nelson SK, Bose SK, Grunwald GK, Myhill P, McCord JM |title=The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy |journal=Free Radic. Biol. Med. |volume=40 |issue=2 |pages=341–7 |date=January 2006 |pmid=16413416 |doi=10.1016/j.freeradbiomed.2005.08.043}} 8. ^{{cite journal |vauthors=Velmurugan K, Alam J, McCord JM, Pugazhenthi S |title=Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement Protandim |journal=Free Radic. Biol. Med. |volume=46 |issue=3 |pages=430–40 |date=February 2009 |pmid=19056485 |doi=10.1016/j.freeradbiomed.2008.10.050}} 9. ^{{cite journal |vauthors=Liu J, Gu X, Robbins D, etal |title=Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model |journal=PLoS ONE |volume=4 |issue=4 |pages=e5284 |year=2009 |pmid=19384424 |pmc=2668769 |doi=10.1371/journal.pone.0005284}} 10. ^{{cite journal |vauthors=Robbins D, Gu X, Shi R, etal |title=The chemopreventive effects of Protandim: modulation of p53 mitochondrial translocation and apoptosis during skin carcinogenesis |journal=PLoS ONE |volume=5 |issue=7 |pages=e11902 |year=2010 |pmid=20689586 |pmc=2912769 |doi=10.1371/journal.pone.0011902}} 11. ^{{cite journal |vauthors=Bogaard HJ, Natarajan R, Henderson SC, etal |title=Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure |journal=Circulation |volume=120 |issue=20 |pages=1951–60 |date=November 2009 |pmid=19884466 |doi=10.1161/CIRCULATIONAHA.109.883843}} 12. ^{{cite journal |vauthors=Qureshi MM, McClure WC, Arevalo NL, etal |title=The Dietary Supplement Protandim Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice |journal=J Diet Suppl |volume=7 |issue=2 |pages=159–178 |date=June 2010 |pmid=20740052 |pmc=2926985 |doi=10.3109/19390211.2010.482041}} 13. ^{{cite journal |vauthors=Joddar B, Reen RK, Firstenberg MS, etal |title=Protandim attenuates intimal hyperplasia in human saphenous veins cultured ex vivo via a catalase-dependent pathway |journal=Free Radic. Biol. Med. |volume=50 |issue=6 |pages=700–9 |date=March 2011 |pmid=21167278 |doi=10.1016/j.freeradbiomed.2010.12.008}} 14. ^1 {{cite news|title=Form 8-K for LifeVantage Corp|url=http://biz.yahoo.com/e/130625/lfvn8-k.html|accessdate=11/10/2013|newspaper=Yahoo.com|date=June 25, 2013}} External links
7 : 1945 births|Living people|American biochemists|University of Colorado Denver faculty|People associated with direct selling|Rhodes College alumni|Duke University alumni |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。